rs1057519874
|
|
Cutaneous Melanoma
|
T |
0.710 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519874
|
|
Cutaneous Melanoma
|
A |
0.710 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519874
|
|
Cutaneous Melanoma
|
|
0.710 |
GeneticVariation
|
BEFREE |
Clinical and pathological associations of the activating RAC1 P29S mutation in primary cutaneous melanoma.
|
25043693 |
2014 |
rs1057519874
|
|
Malignant Uterine Corpus Neoplasm
|
A |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519874
|
|
Malignant Uterine Corpus Neoplasm
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519874
|
|
Squamous cell carcinoma of skin
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519874
|
|
Squamous cell carcinoma of the head and neck
|
A |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519874
|
|
Squamous cell carcinoma of the head and neck
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519874
|
|
Squamous cell carcinoma of skin
|
A |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519874
|
|
melanoma
|
|
0.070 |
GeneticVariation
|
BEFREE |
RAC1 P29S regulates PD-L1 expression in melanoma.
|
26176707 |
2015 |
rs1057519874
|
|
melanoma
|
|
0.070 |
GeneticVariation
|
BEFREE |
The melanoma RAC1(P29S) gain-of-function point mutation therefore represents a previously undescribed class of cancer-related GTPase activity.
|
23284172 |
2013 |
rs1057519874
|
|
melanoma
|
|
0.070 |
GeneticVariation
|
BEFREE |
A point mutation (P29S) in the RAS-related C3 botulinum toxin substrate 1 (RAC1) was considered to be a trigger for melanoma, a form of skin cancer with highest mortality rate.
|
27699663 |
2016 |
rs1057519874
|
|
melanoma
|
|
0.070 |
GeneticVariation
|
BEFREE |
Conversely, RNAi-mediated silencing of endogenous RAC1 P29S in a melanoma cell line with a co-occurring BRAF V600 mutation increased sensitivity to vemurafenib and dabrafenib.
|
25056119 |
2014 |
rs1057519874
|
|
melanoma
|
|
0.070 |
GeneticVariation
|
BEFREE |
Clinical and pathological associations of the activating RAC1 P29S mutation in primary cutaneous melanoma.
|
25043693 |
2014 |
rs1057519874
|
|
melanoma
|
|
0.070 |
GeneticVariation
|
BEFREE |
Here, we describe how the hyperactivation of Rac1 via the P29S mutation (Rac1<sup>P29S</sup>) in melanoma hijacks branched actin network assembly to coordinate proliferative cues that facilitate metastasis and drug resistance.
|
31063759 |
2019 |
rs1057519874
|
|
melanoma
|
|
0.070 |
GeneticVariation
|
BEFREE |
RAC1 is a GTPase member of the RAS superfamily, and RAC1(P29S) was recently identified as the third most common recurrent mutation in melanomas, affecting 4-7% of the patients.
|
25465943 |
2015 |
rs1057519874
|
|
Carcinogenesis
|
|
0.020 |
GeneticVariation
|
BEFREE |
Impact of point mutation P29S in RAC1 on tumorigenesis.
|
27699663 |
2016 |
rs1057519874
|
|
Carcinogenesis
|
|
0.020 |
GeneticVariation
|
BEFREE |
Rac1 P29S mutant is known to strongly promote oncogenesis by facilitating its intrinsic GDP dissociation and thereby increasing the level of the GTP-bound state.
|
30891502 |
2019 |
rs1057519874
|
|
Neoplasms
|
|
0.010 |
GeneticVariation
|
BEFREE |
Enforced expression of RAC1 P29S in sensitive BRAF-mutant melanoma cell lines confers resistance manifested by increased viability, decreased apoptosis, and enhanced tumor growth in vivo upon treatment with RAF inhibitors.
|
25056119 |
2014 |
rs1057519874
|
|
Malignant neoplasm of skin
|
|
0.010 |
GeneticVariation
|
BEFREE |
A point mutation (P29S) in the RAS-related C3 botulinum toxin substrate 1 (RAC1) was considered to be a trigger for melanoma, a form of skin cancer with highest mortality rate.
|
27699663 |
2016 |
rs1057519874
|
|
Neoplasm Metastasis
|
|
0.010 |
GeneticVariation
|
BEFREE |
Here, we describe how the hyperactivation of Rac1 via the P29S mutation (Rac1<sup>P29S</sup>) in melanoma hijacks branched actin network assembly to coordinate proliferative cues that facilitate metastasis and drug resistance.
|
31063759 |
2019 |
rs1057519948
|
|
Squamous cell carcinoma of the head and neck
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519948
|
|
Cutaneous Melanoma
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519948
|
|
Squamous cell carcinoma of skin
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519948
|
|
Malignant Uterine Corpus Neoplasm
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |